Diisopropylethylamine → 3-[4-(Azetidin-1-ylcarbonyl)phenoxy]-5-[(1S)-2-hydroxy-1-methylethoxy]-N-(5-methylpyrazin-2-yl)benzamide

HRID 20559

Reaktionsgleichung

Reaktionsgleichung von HRID 20559
CC[N:3]([CH:7]([CH3:9])C)[CH:4](C)C.[OH:10][CH2:11][C@H:12]([CH3:40])[O:13][C:14]1[CH:15]=[C:16]([CH:27]=[C:28]([C:30]([NH:32][C:33]2[CH:38]=[N:37][C:36]([CH3:39])=[CH:35][N:34]=2)=[O:31])[CH:29]=1)[O:17][C:18]1[CH:26]=[CH:25][C:21]([C:22](O)=[O:23])=[CH:20][CH:19]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.Cl.N1CCC1>CN(C=O)C.O>[N:3]1([C:22]([C:21]2[CH:20]=[CH:19][C:18]([O:17][C:16]3[CH:27]=[C:28]([CH:29]=[C:14]([O:13][C@@H:12]([CH3:40])[CH2:11][OH:10])[CH:15]=3)[C:30]([NH:32][C:33]3[CH:38]=[N:37][C:36]([CH3:39])=[CH:35][N:34]=3)=[O:31])=[CH:26][CH:25]=2)=[O:23])[CH2:4][CH2:9][CH2:7]1

Komponenten

7

Versuchsvorschrift

DIPEA (0.4 mL, 2.08 mmol) was added to a suspension of 4-(3-[(1S)-2-hydroxy-1-methylethoxy]-5-{[(5-methylpyrazin-2-yl)amino]carbonyl}phenoxy)benzoic acid (110 mg, 0.26 mmol), HATU (210 mg, 0.55 mmol) and azetidine hydrochloride (49 mg, 0.52 mmol) in DMF (3 mL) and the mixture stirred at RT for 24 hours. Water (30 mL) was added and the mixture extracted with ethyl acetate (3×15 mL). The combined organic extracts were washed with brine, dried (MgSO4), and evaporated to a residue which was chromatographed on silica, eluting with 5% methanol in ethyl acetate, to give the desired compound (55 mg).

Aufarbeitung

  1. extractionthe mixture extracted with ethyl acetate (3×15 mL)
  2. washThe combined organic extracts were washed with brine
  3. dry with materialdried (MgSO4)
  4. customevaporated to a residue which
  5. customwas chromatographed on silica
  6. washeluting with 5% methanol in ethyl acetate

Quellen und Nachweise

ORD-Eintrag
ord-ce28fb4cf5104a12903315a39263e4f3
Quelldatensatz
uspto-grants-2010_06
Patentnummer
US07745475B2

Verknüpfte Notizen

Wird geladen…